133 related articles for article (PubMed ID: 33323039)
1. Probing the mechanism of peptide binding to REV response element RNA of HIV-1; MD simulations and free energy calculations.
Ali N; Khalil R; Nur-E-Alam M; Ahmed S; Ul-Haq Z
J Biomol Struct Dyn; 2022 Jul; 40(10):4399-4408. PubMed ID: 33323039
[TBL] [Abstract][Full Text] [Related]
2. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.
Lee JH; Culver G; Carpenter S; Dobbs D
PLoS One; 2008 Jun; 3(6):e2272. PubMed ID: 18523581
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition of a branched peptide with HIV-1 Rev Response Element (RRE) RNA.
Dai Y; Peralta AN; Wynn JE; Sherpa C; Li H; Verma A; Le Grice SFJ; Santos WL
Bioorg Med Chem; 2019 Apr; 27(8):1759-1765. PubMed ID: 30879859
[TBL] [Abstract][Full Text] [Related]
5. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.
Sherpa C; Jackson PEH; Gray LR; Anastos K; Le Grice SFJ; Hammarskjold ML; Rekosh D
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867301
[TBL] [Abstract][Full Text] [Related]
7. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
[TBL] [Abstract][Full Text] [Related]
8. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
Litovchick A; Rando RR
RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
[TBL] [Abstract][Full Text] [Related]
9. Evolvability of the mode of peptide binding by an RNA.
Iwazaki T; Li X; Harada K
RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
[TBL] [Abstract][Full Text] [Related]
10. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
11. Molding a peptide into an RNA site by in vivo peptide evolution.
Harada K; Martin SS; Tan R; Frankel AD
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
14. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
15. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex.
Tanamura S; Terakado H; Harada K
J Mol Recognit; 2016 May; 29(5):199-209. PubMed ID: 26620599
[TBL] [Abstract][Full Text] [Related]
16. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
18. Structure of HIV-1 RRE stem-loop II identifies two conformational states of the high-affinity Rev binding site.
Tipo J; Gottipati K; Slaton M; Gonzalez-Gutierrez G; Choi KH
Nat Commun; 2024 May; 15(1):4198. PubMed ID: 38760344
[TBL] [Abstract][Full Text] [Related]
19. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
20. Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis.
Van Ryk DI; Venkatesan S
J Biol Chem; 1999 Jun; 274(25):17452-63. PubMed ID: 10364175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
